HFSA AHFTC Board Certification Review 2026

• Cardio-Oncology for the HF Boards
  Bonnie Ky, MD, MSCE
   
• Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards
  Jon W. Lomasney, MD
   
• Diabetes and COPD
  TBD
   
• Diagnosis and Clinical Assessment
  Mark Drazner, MD, MSc, FHFSA
   
• Healthcare Disparities in HF
  Khadijah Breathett, MD, MS, FHFSA
   
• Heart Failure Epidemiology and Risk Factors
  Clyde Yancy, MD, MSc, FHFSA
   
• Hemodynamics in HF Virtual
  James C. Fang, MD, FHFSA
   
• Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)
  TBD
   
• Management of Comorbidities in Heart Failure - Sleep Disorders
  TBD
   
• Optimal Medical Therapy for HFrEF Virtual
  Mark Drazner, MD, MSc, FHFSA
   
• Pathophysiology 1: Cellular and Energetic Considerations
  Mark Drazner, MD, MSc, FHFSA
   
• Pathophysiology 2: Hemodynamic, Structural and Neurohormonal Considerations
  Daniel Burkhoff, MD, PhD
   
• Pulmonary Hypertension: Classification and Initial Evaluation
  Yasmin Raza, MD, FHFSA  
   
• RV Failure and TR Management
  Barry A. Borlaug, MD
   
• Statistics for the HF Board
  Brian Claggett, PhD

The 2026 HFSA AHFTC Board Certification Review is designed for physicians who are preparing to take the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination or the Maintenance of Certification Assessment Examination, or heart failure specialists seeking an in-depth review in heart failure.

For the Certification Examination in Advanced Heart Failure and Transplant Cardiology:

This course is designed to:

1. Review testable content and the focus of the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination. 
2. Identify gaps in knowledge about advanced heart failure and transplant cardiology.  
3. Explain how to best focus study efforts on filling identified knowledge gaps.  
4. Provide practice for the certification examination with ABIM-style multiple-choice test questions.

For Clinical Practice:

1. Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure. 
2. Discuss the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms. 
3. Assess and treat patients with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers. 
4. Apply guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices. 
5. Incorporate appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, valvular heart disease, pregnancy-associated disease, and cardiorenal syndrome. 
6. Explain the genetic basis of cardiomyopathies, including hypertrophic cardiomyopathy, and recognize when to pursue genetic testing as part of the evaluation of patients with suspected inherited heart failure syndromes. 
7. Manage comorbidities in patients with chronic heart failure, including sleep-disordered breathing, anemia, and diabetes. 
8. Implement strategies for effective disease management of patients with advanced heart failure, including referral for mechanical circulatory support, heart transplant, or palliative care. 
9. Manage immunosuppressive therapies and common complications of heart transplant, including rejection, allograft vasculopathy, and immunosuppression-associated conditions. 
10. Utilize mechanical support devices, both temporary and durable. 
11. Manage common complications of mechanical circulatory support.